NCT07800884

Brief Summary

The goal of this clinical trial is to explore the correlation between dietary patterns, anthropometric measurements, genetic profiles, and biomarker levels and their impact on glucose levels and other relevant biomarkers in diabetes in healthy adults. The primary objective is to examine the correlation between dietary patterns, anthropometric measurements, genetic profiles, and biomarker levels and their impact on glucose levels and other relevant biomarkers in the context of diabetes. Secondary Objectives:

  • To examine the relationship between the diabetes parameters, dietary patterns, anthropometric measurements, genetic profiles, and biomarker levels in the intervention group and control group following a month-long diet.
  • To examine the correlation between subjects' characteristics (age, sex, educational background, ethnic background, and economic status) and diabetes parameters
  • To examine the correlation between subjects' life habits (exercise, smoking, sleeping) and diabetes parameters
  • To examine the compliance of subjects to study intervention
  • To examine the progression of anthropometric measurements during the study period
  • The process involves identifying changes between markers related to the development of diabetes.
  • To develop a risk prediction of diabetes based on dietary intake and health indicators. Hypothesis: There was a correlation between dietary patterns, anthropometric measurements, genetic profiles, and biomarker levels and their impact on glucose levels and other relevant biomarkers in the context of diabetes. Participants: One hundred fifty individuals will participate in the study, providing substantial data for analysis. Participants will undergo dietary interventions and biomarker testing (continuous and checkpoint) to establish baseline data for health indicators, specifically diabetes. Three groups of participants will be recruited:
  • Case group: Balanced healthy diet group, eating 45-65% of calories from carbohydrates, 20-25% of calories from fat, and 10% from protein.
  • Low-carb diet group: an eating pattern with \<45% of total energy provided by carbohydrates. This group will undergo two different meal diets to see changes in blood biomarkers due to specific diet variations.
  • Control group: this group will not receive a diet intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
181

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 28, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 16, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 2, 2025

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 16, 2026

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 2, 2026

Completed
Last Updated

September 2, 2026

Status Verified

September 1, 2026

Enrollment Period

3 months

First QC Date

June 16, 2026

Last Update Submit

September 1, 2026

Conditions

Keywords

dietdiabetes mellitusgeneticbiomarker

Outcome Measures

Primary Outcomes (3)

  • HbA1C

    will be presented as a percentage.

    at enrollment and at the end of treatment in week 4

  • Fasting glucose

    will be presented in mg/dL

    at enrollment and at the end of treatment in week 4

  • Fasting insulin

    will be presented in μU/mL

    at enrollment and at the end of treatment in week 4

Secondary Outcomes (9)

  • Body weight

    at enrollment and at the end of treatment in week 4

  • Body mass index

    at enrollment and at the end of treatment in week 4

  • Cholesterol

    at enrollment and at the end of treatment in week 4

  • Low density cholesterol (LDL)

    at enrollment and at the end of treatment in week 4

  • High density cholesterol (HDL)

    at enrollment and at the end of treatment in week 4

  • +4 more secondary outcomes

Study Arms (3)

balanced, healthy diet

EXPERIMENTAL

Balanced healthy diet group, eating 45 - 65% of calories from carbohydrates, 20 - 25% of calories from fat, and 10% from protein

Other: diet intervention

a low-carbohydrate diet group

EXPERIMENTAL

Low-carb diet group, eating pattern with less than 45% of total energy provided by carbohydrates.

Other: diet intervention

Control group

NO INTERVENTION

Subjects in the control group did not receive a special diet, only their dietary intake was monitored.

Interventions

Subjects in the treatment group will be given a balanced diet or low-carb diet based on the amount of carbohydrates given.

a low-carbohydrate diet groupbalanced, healthy diet

Eligibility Criteria

Age18 Years - 59 Years
Sexall(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 18-59 years
  • Participants must provide informed consent to participate in the study, which include dietary tracking, biometric testing, and adherence to the intervention program.
  • Participants must be available for the full duration of the study (one months) and able to comply with the scheduled meal plans and testing appointments.

You may not qualify if:

  • Individuals with history of type 1 and 2 diabetes, autoimmune, thyroid disease, which may affect carbohydrate metabolism.
  • Individuals who have experienced major surgery in the past six months, as it might impact carbohydrate metabolism and the body's reaction to dietary modifications.
  • Individuals with eating disorders, given the potential risks associated with dietary changes and the focus on food intake and biometrics.
  • Individuals with allergies or intolerances to the ingredients used in the study's meal plans to prevent adverse health effects and ensure participant safety.
  • Individuals currently participating in other clinical trials that could influence the outcomes of this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine Universitas Trisakti

Jakarta, DKI Jakarta, 11440, Indonesia

Location

Related Publications (2)

  • Yu EY, Ren Z, Mehrkanoon S, Stehouwer CDA, van Greevenbroek MMJ, Eussen SJPM, Zeegers MP, Wesselius A. Plasma metabolomic profiling of dietary patterns associated with glucose metabolism status: The Maastricht Study. BMC Med. 2022 Nov 21;20(1):450. doi: 10.1186/s12916-022-02653-1.

  • Esmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC. Dietary patterns, insulin resistance, and prevalence of the metabolic syndrome in women. Am J Clin Nutr. 2007 Mar;85(3):910-8. doi: 10.1093/ajcn/85.3.910.

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 16, 2026

First Posted

September 2, 2026

Study Start

April 28, 2025

Primary Completion

July 16, 2025

Study Completion

September 2, 2025

Last Updated

September 2, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

IPD will not or may not be shared to maintain the confidentiality of subject data.

Locations